Trinity Biotech PLC - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Trinity Biotech PLC Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Trinity Biotech PLC. The Group's principal activity is developing, manufacturing and marketing diagnostic test kits used for the clinical laboratory and point-of-care segments of the diagnostic market. These test kits are used to detect infectious diseases, sexually transmitted diseases, blood coagulation disorders and autoimmune disorders. The Group is also a provider of raw materials to the life sciences industry. Products brands are Amax, Biopool, CAPTIA, Macra, MicroTrak, Uni-Gold, Amelung, Bartels, Capillus, SeroCard, Recombigen and MarDx. The Group operates in Ireland, the United Kingdom, the United States of America, Germany and Sweden.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report